Introduction

M
umps is an acute self-limited infection characterized by fever, bilateral or unilateral parotid swelling and tenderness. It is caused by mumps virus which belongs to Paramyxoviridae family and the genus Rubulavirus. Mumps can occur at any age but it primarily aff ects the school going children between 5-9 years of age. There is increased incidence in winter and spring season 1 . Mumps infection is endemic in developing countries because of poor vaccination coverage. Humans are the only known host. It is transmitted by droplet spread or by direct contact with infected cases. Mumps virus commonly targets the salivary gland, central nervous system, pancreas and testes 2 . Lack of immunization, travelling and immune defi ciencies can make a child more prone to infection. Lifelong immunity follows after natural infection 2 . The incubation period is 12-25 days with period of maximum infectivity being 2 days prior to 5 days after the parotid swelling 3,4, 5 . Patient may present with prodromal symptoms of fever, headache malaise, vomiting followed by unilateral parotid gland swelling 6 . The enlargement of contra lateral gland occurs 1-5 days later in almost 70% of the cases 2,7 . Complications are usually infrequent but infection can progress to meningitis, encephalitis, pancreatitis, oophoritis, orchitis, epididymitis, leading to sterility or infertility and rarely sensorineural hearing loss, myocarditis, pneumonia, transient renal dysfunction, thyroiditis, optic neuritis etc 8 . Diagnosis of mumps is usually clinical on the basis of history, presence of parotid swelling (Parotitis) unilateral or bilateral and history of exposure but several non-specifi c fi ndings may be present in blood like: elevated WBC count with lymphocyte predominance, increased serum amylase level. Other tests that can be done are: Solid phase ELISA, Virus isolation from the CSF during the fi rst 2-3 days of disease onset. Now a newer diagnostic confi rmation using real time nessed polymerase chain reaction has been developed 9 . But none of these tests are available in Nepal. In cases of complication further testing is required to determine the organ system involved.
Treatment is usually conservative and symptomatic with analgesics, antipyretics, along with bed rest, soft light diet and generous fl uid intake. In case of complication it may require admission and further management. The only eff ective way to prevent mumps is by vaccination.
Mumps is generally a mild disease but can cause unnecessary sufferings and absenteeism from school and work and may lead to rare but serious complications. As data provided by WHO, there were 29,022 reported cases of mumps from Nepal (data as of 20-September-2011) 10 . To our knowledge there hasn't been any study done in Nepal and there is no schedule for mumps vaccination till date in routine national immunization programme of Nepal. Hence this study is intended to highlight the increased number of mumps cases in children attending tertiary care center in Nepal and thus to emphasize the importance of mumps vaccination, so as to decrease the disease occurrence and disease burden by vaccinating all children.
Materials and Methods
This was a prospective study done in Civil Service Hospital of Nepal over a period of 2 years from November 2009 to October 2011. All children less than 14years of age with symptoms of fever and parotid swelling were included in the study group. A detailed history pertaining to the disease was taken, that included; history of exposure and prior vaccination against mumps. Children were asked to follow up either after 5 days or in case of noticing any signs and symptoms of complication. There is no virological test available in Nepal to diagnose mumps hence the diagnosis of mumps in our study was completely on clinical grounds.
Results
In this study there were a total of 113 clinically diagnosed cases of mumps out of which there were 71 males and 42 females with male:female ratio being 1.69:1.
Only 7(6.19%) out of 113 children with mumps were admitted in our hospital for management of mumps complication, out of which four children were managed for mumps cellulitis and three for mumps pancreatitis.
None of the children were vaccinated against mumps. Most of the school going children had to be absent from school for the period of 3-5 days.
J a n u a r y During 2006, a total of 6584 confirmed and probable cases of mumps were reported in United States to the Centers for Disease Control and Prevention and most of these, 5865, occurred between January 1 and July 31 with the peak of the outbreak was in April 1 . There was increased incidence of mumps in 5-14years of age as shown in study done by Galbraith in Wales in 1986 with peak from JuneAugust and a later peak in December 11 .
In the study done by T. Jacob John during an outbreak of mumps in Thiruvananthapuram district in 2002, they found that over a period of 3 months the peak prevalence was seen in 5-9 years age, with 98 reported cases out of total 179, and there as a male preponderance The study also revealed an outbreak with a peak during Jan-March 12 .
In the study done by Hashimoto H, they reported that most of the mumps cases occured in school aged children of 5-14yrs age (60%) during 1985-1987 13 . Another study done by SR Palmer also confi rms that most of them occurred in preschool children 14 .
Painful swelling of the salivary glands (classically the paro d gland) is the most typical presentation 15 . Our study showed that 49(43.36%) had bilateral and 64(56.63%) had unilateral parotid swelling. All the children had to be off school or work for a period of 3-5 days.
We also found that none of the children were vaccinated against mumps. 
Conclusion
Mumps was one of the common viral illnesses in children attending pediatric OPD of our hospital. All of them presented with fever and parotitis and none of them were vaccinated. All of the children had to be off school and work for a period of 3-5 days. Though the disease is self limiting, child can be prevented from the infection by vaccination and thus avoiding possible suff erings and complications. Thus we recommend the use of mumps vaccination as a part of the routine immunization programme in Nepal. 
